Allarity Therapeutics and Detsamma Investments, trading as FivepHusion, have recently announced a significant clinical collaboration agreement for the development of Deflexifol. Advancing Treatment for Solid Tumors The collaboration aims to propel the clinical development of Deflexifol, a novel anti-cancer drug reformulation, for the treatment of solid tumors. Allarity will … [Read more...] about Clinical Collaboration Agreement for Deflexifol
Footer
